The FDA recently approved marketing of the first prescription device as a preventative treatment for migraine headaches.
Illumina announced recently that they have broken the “sound barrier” of human genomics by enabling the $1,000 genome.
In January 2012, we introduced you to the Scanadu Medical Tricorder, a mobile diagnostic device that measures key vital signs and sends all information directly to your smartphone. Last week, the company launched a crowdfunding campaign to put the device — now called the Scanadu Scout — into production.
Scientists from the EPFL (École polytechnique fédérale de Lausanne or, in English, Swiss Federal Institute of Technology in Lausanne) have developed an implantable blood testing laboratory that provides an immediate analysis of compounds in the body. The device will allow for a greater level of personalized care than traditional blood tests currently provide.
For patients who have lost their vision due to degenerative retinal disease, the dream of seeing again might just be a reality. After a unanimous recommendation for approval by the Ophthalmic Devices Advisory Panel in September 2012, the Food and Drug Administration (FDA) has now officially approved Second Sight’s Argus II Retinal Prosthesis System, aka “the bionic eye” .